Caroline Evelyn Bass

Caroline Evelyn Bass

Auto-generated profile, based on publicly available information

Caroline Evelyn Bass

Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo Buffalo, NY, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2014 in Nature Methods
Verified
Journal Article
Closed access
PDF file
LFLief E Fenno
Lief E Fenno
JMJoanna Mattis
Joanna Mattis
CRCharu Ramakrishnan
Charu Ramakrishnan
MHMinsuk Hyun
Minsuk Hyun
SLSoo Yeun Lee
Soo Yeun Lee
KDKarl Deisseroth
Karl Deisseroth

5 August 2007 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
Michael LazarusMichael Lazarus
Michael Lazarus
KYKyoko Yoshida
Kyoko Yoshida
RCRoberto Coppari
Roberto Coppari
CBCaroline E Bass
Caroline E Bass
TMTakatoshi Mochizuki
Takatoshi Mochizuki
CSClifford B Saper
Clifford B Saper

17 August 2014 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
CAChristelle Anaclet
Christelle Anaclet
LFLoris Ferrari
Loris Ferrari
EAElda Arrigoni
Elda Arrigoni
CBCaroline E Bass
Caroline E Bass
CSClifford B Saper
Clifford B Saper
PFPatrick M Fuller
Patrick M Fuller
Using a combination of targeted activation and optogenetic-based mapping in mice, this study demonstrates that sleep-active GABAergic neurons in the medullary parafacial zone promote slow wave sleep and cortical slow wave activity and uncovers functional circuit connections linking these neurons with the cortex. Work in animals and humans has suggested the existence of a slow wave sleep (SWS)-promoting/electroencephalogram (EEG)-synchronizing center in the mammalian lower brainstem. Although sleep-active GABAergic neurons in the medullary parafacial zone (PZ) are needed for normal SWS, it remains unclear whether these neurons can initiate and maintain SWS or EEG slow-wave activity (SWA) in behaving mice. We used genetically targeted activation and optogenetically based mapping to examine the downstream circuitry engaged by SWS-promoting PZ neurons, and we found that this circuit uniquely and potently initiated SWS and EEG SWA, regardless of the time of day. PZ neurons monosynaptically innervated and released synaptic GABA onto parabrachial neurons, which in turn projected to and released synaptic glutamate onto cortically projecting neurons of the magnocellular basal forebrain; thus, there is a circuit substrate through which GABAergic PZ neurons can potently trigger SWS and modulate the cortical EEG.

6 July 2011 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
Michael LazarusMichael Lazarus
Michael Lazarus
Hai-Ying ShenHai-Ying Shen
Hai-Ying Shen
YCYoan Cherasse
Yoan Cherasse
WQWei-Min Qu
Wei-Min Qu
Zhi-Li HuangZhi-Li Huang
Zhi-Li Huang
JCJiang-Fan Chen
Jiang-Fan Chen
Caffeine, the most widely used psychoactive compound, is an adenosine receptor antagonist. It promotes wakefulness by blocking adenosine A2A receptors (A2ARs) in the brain, but the specific neurons on which caffeine acts to produce arousal have not been identified. Using selective gene deletion strategies based on the Cre/loxP technology in mice and focal RNA interference to silence the expression of A2ARs in rats by local infection with adeno-associated virus carrying short-hairpin RNA, we report that the A2ARs in the shell region of the nucleus accumbens (NAc) are responsible for the effect of caffeine on wakefulness. Caffeine-induced arousal was not affected in rats when A2ARs were focally removed from the NAc core or other A2AR-positive areas of the basal ganglia. Our observations suggest that caffeine promotes arousal by activating pathways that traditionally have been associated with motivational and motor responses in the brain.

3 November 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
CAChristelle Anaclet
Christelle Anaclet
NPNigel P. Pedersen
Nigel P. Pedersen
LFLoris L. Ferrari
Loris L. Ferrari
AVAnne Venner
Anne Venner
CBCaroline E. Bass
Caroline E. Bass
PFPatrick M. Fuller
Patrick M. Fuller
Wakefulness, along with fast cortical rhythms and associated cognition, depend on the basal forebrain (BF). BF cholinergic cell loss in dementia and the sedative effect of anti-cholinergic drugs have long implicated these neurons as important for cognition and wakefulness. The BF also contains intermingled inhibitory GABAergic and excitatory glutamatergic cell groups whose exact neurobiological roles are unclear. Here we show that genetically targeted chemogenetic activation of BF cholinergic or glutamatergic neurons in behaving mice produced significant effects on state consolidation and/or the electroencephalogram but had no effect on total wake. Similar activation of BF GABAergic neurons produced sustained wakefulness and high-frequency cortical rhythms, whereas chemogenetic inhibition increased sleep. Our findings reveal a major contribution of BF GABAergic neurons to wakefulness and the fast cortical rhythms associated with cognition. These findings may be clinically applicable to manipulations aimed at increasing forebrain activation in dementia and the minimally conscious state.

17 February 2008 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
SASharon M Anderson
Sharon M Anderson
KFKatie R Famous
Katie R Famous
GSGhazaleh Sadri-Vakili
Ghazaleh Sadri-Vakili
VKVidhya Kumaresan
Vidhya Kumaresan
HSHeath D Schmidt
Heath D Schmidt
RPR Christopher Pierce
R Christopher Pierce